Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001102948-15-000001
Filing Date
2015-06-03
Accepted
2015-06-03 19:47:29
Documents
1
Period of Report
2015-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3834
  Complete submission text file 0001102948-15-000001.txt   5432
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CDS INTERNATIONAL HOLDINGS 3299 NW SECOND AVE BOCA RATON FL 33431
Business Address
DESANTIS CARL (Reporting) CIK: 0001102948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 15911601